These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1793470)

  • 1. Synthesis and immunomodulating activity of condensed N-aryl-2-cyano-3-oxo-3-pyrazolyl-propanamides.
    Doria G; Isetta AM; Ferreccio R; Ferrari M; Fornasiero MC; Tibolla M; Rossi M; Carlini O; Motta P; Magistrelli M
    Farmaco; 1991; 46(7-8):843-60. PubMed ID: 1793470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities.
    Bruno O; Ranise A; Bondavalli F; Schenone P; D'Amico M; Filippelli A; Filippelli W; Rossi F
    Farmaco; 1993 Jul; 48(7):949-66. PubMed ID: 8397678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal antiinflammatory agents. Synthesis of novel 2-pyrazolyl-4(3H)-quinazolinones.
    Farghaly AM; Chaaban I; Khalil MA; Bekhit AA
    Arch Pharm (Weinheim); 1990 Oct; 323(10):833-6. PubMed ID: 2080894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimicrobial activity of novel pyrazole, pyrazoline, pyrazolinone and pyrazolidinedione derivatives of benzimidazole.
    Soliman R; Habib NS; Ashour FA; el-Taiebi M
    Boll Chim Farm; 2001; 140(3):140-8. PubMed ID: 11486603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a potent inhibitor for mammalian elongase of long-chain fatty acids family 6: examination of its potential utility as a pharmacological tool.
    Shimamura K; Kitazawa H; Miyamoto Y; Kanesaka M; Nagumo A; Yoshimoto R; Aragane K; Morita N; Ohe T; Takahashi T; Nagase T; Sato N; Tokita S
    J Pharmacol Exp Ther; 2009 Jul; 330(1):249-56. PubMed ID: 19359527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile synthesis of fused pyrazolo[1,5-a]pyrimidinepyrazolo [1,5-a]triazines and N-sulphonamidopyrazoles as antiinflammatory.
    Fathalla OA; Zaki ME; Swelam SA; Nofal SM; el-Eraky WI
    Acta Pol Pharm; 2003; 60(1):51-60. PubMed ID: 12848368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,5-Diphenyl-1H-pyrazole derivatives. IV--N,N-disubstituted 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamides and 3-(3,5-diphenyl-1H-pyrazol-1-yl)propanamines with sedative, platelet antiaggregating and local anesthetic activities.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Donnoli D; Stella L; Marmo E
    Farmaco; 1990 Feb; 45(2):137-46. PubMed ID: 2133991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
    Jönsson S; Andersson G; Fex T; Fristedt T; Hedlund G; Jansson K; Abramo L; Fritzson I; Pekarski O; Runström A; Sandin H; Thuvesson I; Björk A
    J Med Chem; 2004 Apr; 47(8):2075-88. PubMed ID: 15056005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents.
    Bekhit AA; Fahmy HT
    Arch Pharm (Weinheim); 2003 Apr; 336(2):111-8. PubMed ID: 12761764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,5-Diphenyl-1H-pyrazole derivatives. VIII. N-substituted 3-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)-propanamides, -propanamines and 2-(4-hydroxy-3,5-diphenyl-1H-pyrazol-1-yl)ethanamines with platelet antiaggregating, hypotensive, antiarrhythmic and other activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Cenicola ML; Donnoli D; Filippelli W; Losasso C; Costantino M; Marmo E
    Farmaco; 1991 Mar; 46(3):477-99. PubMed ID: 1892504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists.
    Lattmann E; Singh H; Boonprakob Y; Lattmann P; Sattayasai J
    J Pharm Pharmacol; 2006 Mar; 58(3):393-401. PubMed ID: 16536908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
    Ali MA; Shaharyar M; Siddiqui AA
    Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antinociceptive activity of pyrazolyl isoxazolines and pyrazolyl isoxazoles.
    Karthikeyan K; Veenus Seelan T; Lalitha KG; Perumal PT
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3370-3. PubMed ID: 19481931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-substituted 4-carboxy-1-phenyl-1H-pyrazole-5-propanamides with antiinflammatory, analgesic, antipyretic and platelet antiaggregating activities.
    Menozzi G; Mosti L; Schenone P; D'Amico M; Falzarano C; Rossi F
    Farmaco; 1993 Apr; 48(4):539-49. PubMed ID: 8357469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunomodulating effect of the novel water-soluble gossypol derivative Mebavin in adjuvant arthritis].
    Sabirova FM; Urazmetova MD; Madaminov AA
    Eksp Klin Farmakol; 2004; 67(2):51-4. PubMed ID: 15188763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.
    Sakya SM; Hou X; Minich ML; Rast B; Shavnya A; DeMello KM; Cheng H; Li J; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1067-72. PubMed ID: 17126015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimicrobial activity of 3-(4'-hydroxy-3'-methylphenyl)-5-[(substuted) phenyl]-4,5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives.
    Yar MS; Ali MA; Sriram D; Yogeeswari P
    Acta Pol Pharm; 2006; 63(6):491-6. PubMed ID: 17438865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents.
    Khode S; Maddi V; Aragade P; Palkar M; Ronad PK; Mamledesai S; Thippeswamy AH; Satyanarayana D
    Eur J Med Chem; 2009 Apr; 44(4):1682-8. PubMed ID: 18986738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.